KNTE.US Tender Offer

XRA 1 Corp. , a Delaware corporation (Purchaser), a wholly owned subsidiary of XOMA Corporation, is offering to purchase (the Offer) all outstanding shares of common stock, par value USD 0.0001 per share (Shares), of Kinnate Biopharma Inc., a Delaware corporation (Kinnate), for (i) USD 2.3352 per Share in cash (the Base Price Per Share), (ii) an additional amount of cash of up to USD 0.2527 per Share (such amount as finally determined pursuant to the Merger Agreement (as defined below), the Additional Price Per Share and together with the Base Price Per Share, the Cash Amount), and (iii) one non-transferable contractual contingent value right for each Share (each, a CVR, and each CVR together with the Cash Amount, the Offer Price), all upon the terms and subject to the conditions described in this Offer to Purchase (together with any amendments or supplements hereto, this Offer to Purchase) and in the related Letter of Transmittal (together with any amendments or supplements thereto, the Letter of Transmittal). Accordingly, the total Cash Amount that Purchaser may pay pursuant to the terms of the Offer and Merger Agreement is between USD 2.3352 and USD 2.5879 per Share. Participants must obtain the Offer to purchase, related Letter of Transmittal, Notice of Guaranteed Delivery and Schedule 14D-9, dated 04/03/2024 for complete terms and conditions of the offer. Participants should consult their tax advisor for complete details in reference to withholding taxes.

The terms of the offer are as follows:

Option (1): Take no action [Default option]

Option (2): Tender Shares – BETWEEN US$2.3352 & US$2.5879 PER SHARE (TBD) NET IN CASH + 1 CVR PER SHARE (less any applicable withholding taxes）

The deadline to tender shares to the offer will be 22/03/2024@ 16:00 (HONG KONG TIME GMT+8).

In the absence of an election, no action will be taken.

Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.

1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: KNTE.US
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:

Note to applicants:
1. For shareholders holding less than 1 share of KNTE.US, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option (1) if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.

Helpful？

Yes No